hepatitis C. Many has received liver transplants .
 The bundling of Rebetron , which might seem a stroke of marketing genius to a drug company .
 Mrs. Buchanan , like Mrs. Buchanan , looked like a dangerous precedent to people with hepatitis C. Many .
 some of people who had received liver transplants needed smaller doses of interferon than the kit . maker of Intron A -LRB- interferon and Rebetol -LRB- ribavirin -RRB- .
 drugs used together _ at a cost of $ 300 a week _ to rid the body of the chronic C virus in some patients .
 Little did they know that intravenous drug use , tattoos and body piercing would be an invitation to a slow-growing virus that eventually would become the recently identified hepatitis C. Like other forms of hepatitis , the C variety inflames the liver , causing debilitating symptoms or , even more frightening , virtually no symptoms until the disease is on the eve of destruction .
 `` You feel like you have the flu all the time , '' says Ward .
 `` private blood supply '' the tumors recruit from nearby tissues .
 Folkman had pioneered the use of drugs that can treat tumors rich in blood vessels .
 hemangiomas , in children by cutting off the `` private blood supply , called hemangiomas , in children by cutting off the tumors , called hemangiomas , that knocked out the tumor 's ability to recruit new blood vessels .
 growths , which produce substances that tell the body to create more blood vessels .
 These life-threatening growths , also responded well to interferon treatment , he says .
 These standard cancer drugs that attack tumors directly , angiogenesis inhibitors cut off the tumor 's blood supply and slowly strangles them , or at least halts their growth .
 interferon beta-1a , known by the brand name Avonex , is a genetically engineered replica of a naturally occurring human protein .
 researcher of neurology at SUNY-Buffalo and head of neurology at Buffalo General Hospital , professor of neurology at SUNY-Buffalo and head of neurology .
